KRB-456 Suppresses the Levels of KRAS Bound to GTP, Inhibits the Binding of KRAS to RAF1, and Deceases P-MEK and P-ERK Levels in Human Pancreatic Cancer Cells. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.